Pharmafile Logo

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trials are essential for the development of new treatments that can transform patient’s lives. So far, in our Clinical Trial Considerations series, we have focused on how to best support patients throughout the process and on ways to improve their experience. And while it is true that patients have a large part to play in trials, it is important not to overlook the crucial role of healthcare professionals (HCPs) in ensuring the success of clinical research. So how can we help to support HCPs, too?

HCPs play a key role in identifying and recruiting eligible patients, as well as guiding them through the informed consent process and ensuring participants fully understand the potential risks and benefits of taking part. We shouldn’t underestimate how challenging a task this can be, especially when the clinical study protocols provided are often 300+ pages. Throughout the trial, HCPs are also responsible for monitoring patient health and managing any adverse events. Keeping track of symptoms, offering advice to help control them, and realising when more serious intervention may be required is vital for patient safety. No easy feat.

Which is why information in a digestible format is so important for everyone involved.

For example, providing timely and relevant information really can enhance a HCP’s ability to communicate it effectively. When HCPs are equipped with the information they need to aid their own understanding, they find it easier to convey it to patients using simplified language and maintaining a confident and calm tone.

Which is why we design specialised discussion aids for HCPs to use when communicating with patients. And just like clinical trial materials for patients, employing health literacy principles and using imagery where possible in HCP materials also helps to draw out key information and keep the content concise. Which is also why effective HCP materials not only improve the patient experience but also enhance patient recruitment and retention, key success indicators for HCPs conducting clinical studies.

So, whether it’s recruitment aids that quickly inform who may be eligible for a trial, or toxicity management guides that highlight potential adverse events and how to manage them, providing HCPs with support, and in varying formats, at each stage of the clinical trial process is key to future study success.

If you’d like to find out more about the support we can offer HCPs, and how it could support your next trial, let’s talk.

You can read all our latest clinical trials explained blogs here.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...